[177Lu]Lu-PSMA-617 clinical trials

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

This study looks at new ways to treat prostate cancer that has spread. It uses special scans to find cancer cells and then delivers targeted radiation therapy to those cells, aiming to see how well it works and if it's safe.